Skip to main content

Latest News

RELEASE: Alexander Kim Appointed AD 74 District Director

Office of Assemblywoman Petrie-Norris

SACRAMENTO – Assemblywoman Cottie Petrie-Norris has hired Alexander Kim as her new District Director. In this role, Alexander will serve as a community liaison based out of the Assemblywoman’s Irvine office for the cities of Huntington Beach, Newport Beach, Costa Mesa, Irvine, Laguna Woods and Laguna Beach.
 

RELEASE: Legislation Introduced to Protect Patients in Recovery

Insuring Safety in Recovery (AB 1158) will require minimum insurance coverage, higher standards and reporting of hospitalizations and deaths

SACRAMENTO - In order to protect the safety of patients recovering from alcohol and substance use, Assemblywoman Cottie Petrie-Norris, in collaboration with Insurance Commissioner Ricardo Lara, introduced AB 1158 on Thursday, February 18, 2021. This bill will ensure that licensed drug abuse recovery and treatment facilities and recovery residences that contract with the government maintain minimum insurance coverage levels and higher standards to protect patients from abuse or injury. 

RELEASE: Immediate Relief for Small Businesses Quadrupled

$1.5BB Additional Relief Secured for Small Businesses & Nonprofits

SACRAMENTO – Governor Gavin Newsom, Senate President pro Tempore Toni G. Atkins and Assembly Speaker Anthony Rendon today announced a $9.6BB economic recovery package, including immediate actions to substantially increase aid for California small businesses & nonprofits who have been devastated by the COVID-19 pandemic (RELEASE).

RELEASE: What Others Are Saying About the Golden State Innovation Act

Investing in Life Sciences is an Investment in CA’s Future

SACRAMENTO – At a virtual press conference, Assemblymembers Cottie Petrie-Norris, Tom Daly, Kevin Mullin and Jacqui Irwin unveiled coalition support and legislative details of the Golden State Innovation Act. Assembly Bill 593 will restore the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deductions for Life Sciences companies in California, at a pivotal point in the state’s pandemic response and recovery.